Jun 24
Shionogi, the Japanese company that makes Xocova (ensitrelvir), said the post-exposure prophylaxis drug will be available in mid-July in the
Saved in our archive
Loading...
seen from Germany
seen from United States
seen from United States
seen from United States
seen from Pakistan
seen from Netherlands
seen from Malaysia
seen from Saudi Arabia
seen from United States
seen from United Kingdom
seen from Malaysia
seen from United Kingdom
seen from China
seen from United States
seen from United States
seen from United States
seen from United States
seen from Germany
seen from United States
seen from United Kingdom
Shionogi, the Japanese company that makes Xocova (ensitrelvir), said the post-exposure prophylaxis drug will be available in mid-July in the
Saved in our archive
Anya is live and ready to show you everything. Watch her strip, dance, and perform exclusive shows just for you. Interact in real-time and make your fantasies come true.
Free to watch • No registration required • HD streaming
In June, the Food and Drug Administration approved the drug Xocova (ensitrelvir) as the very first post-exposure prophylaxis for Sars-CoV-2,
Saved in our archive